by Grow Up Conference | Jul 5, 2023 | Cannabis News Wire, Media Partners
According to a forecast from a top marijuana law firm, Minnesota’s legalized marijuana market will increase to more than $1.5 billion annually by 2029. Nearly 700,000 adult-use and medicinal marijuana users are anticipated to be served by Minnesota cannabis companies as the industry matures.
Travis Copenhaver, a partner at the psychedelics and cannabis law firm Vicente LLP, stated at a seminar on marijuana entrepreneurship recently held by Surly Brewing in Minneapolis that the state’s recent legalization of recreational cannabis highlights new economic prospects for entrepreneurs in Minnesota. Vicente’s market analysis suggests that Minnesota’s legal marijuana market growth will closely resemble trends observed in other states.
Upon the commencement of recreational cannabis sales, the market will experience limited supplies, resulting in higher prices. However, as more retailers and producers enter the market, supplies will rise, leading to a decline in prices. It is predicted that the state’s overall marijuana economy will reach its peak, approximately $1.5 billion annually, in the next 10 years. According to the projection, 650,000 Minnesotans, or 15% of the state’s population aged 21 and older, are expected to use cannabis once a month or more regularly.
However, convincing current recreational cannabis users to switch to the regulated market won’t happen quickly. The estimates predict that the great majority of people won’t be able to purchase marijuana from licensed merchants until 2030. Minnesota lifted its prohibition on cannabis last month, following Governor Tim Waltz’s signing of a bill legalizing recreational cannabis in the state. Starting August 1, 2023, adults aged 21 years and older will be permitted to possess up to two ounces of marijuana in public places. The legislation also permits persons aged 21 and older to cultivate a small amount of cannabis in their homes as well as possess up to two pounds of marijuana in private residences.
It also makes it legal for businesses to produce and sell cannabis, and it also permits the sale of recreational marijuana under certain conditions, subject to regulations developed and approved by the marijuana management office, a newly established state agency. The new organization will also control hemp-derived cannabis goods and medical marijuana.
According to Minnesota Public News, state authorities have set a goal date of May 2024 for when they will start accepting applications for recreational marijuana retail stores. Thereafter, sales are expected to begin in January 2025. Once regulated sales of recreational cannabis commence, adults will have the freedom to purchase eight grams of marijuana concentrate and edible products containing a maximum of 800mg of THC.
When this marijuana market opens and takes off, many opportunities could open up for many enterprises, including those that operate similar to Advanced Container Technologies Inc. (OTC: ACTX), supporting marijuana companies but not directly dealing with marijuana products.
NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CNW420 is part of the InvestorBrandNetwork.
by Grow Up Conference | Jul 5, 2023 | Media Partners, Psychedelic News Wire
As America has become increasingly progressive in its drug policy, psychedelics have turned from relatively obscure drugs enjoyed by a niche community to potentially game-changing mental-health treatments. Studies on hallucinogenic drugs such as psilocybin (magic mushrooms), MDMA and ayahuasca have found that these substances can safely and effectively treat various mental disorders with little side effects and at minimal doses.
With the country facing an unprecedented mental-health crisis, the populace has mostly welcomed news of treatments that could potentially treat severe mental-health disorders. Public attention on psychedelics has been bolstered even more by public figures’ and celebrities’ accounts of their hallucinogenic experiences.
The recently concluded Psychedelic Science 2023 convention was host to speakers such as NFL star Aaron Rodgers, author Michael Polan, and writer and businessman John Mackey sharing their thoughts and experiences on psychedelics with over 10,000 attendees. In addition, actor and rapper Jaden Smith joined the panelists and discussed his use of plant medicines and psychedelics.
Smith revealed that he prefers to use natural medicines such as psychedelics over other stimulants because they “connect him to nature.” He noted that although he has always felt a connection with nature, psychedelics allowed him to access a much deeper layer of connection he never thought was possible.
Multitudes of anecdotal reports and a number of studies have corroborated what Smith experienced: psychedelics seem to enhance people’s connection with nature as well as, in many cases, themselves. Higher connectedness to nature has been tied to greater life meaning, reduced anxiety levels, improvements in psychological well-being, and vitality and happiness. Furthermore, people with higher rates of nature connectedness tend to value intrinsic aspirations such as intimacy, personal growth, and community instead of extrinsic aspirations such as image, money, and fame.
According to Smith, his first experience with natural drugs was a major turning point in how he understood himself and nature. Elaborating on his history with psychedelics, Smith says that his mother took the first steps into the world of psychedelics and this encouraged the rest of the family to follow suit. Smith says natural medicine helped him develop profound levels of love and empathy and allowed him to form deeper bonds with his family.
The 22-year-old emphasized the need for having a safe space when using psychedelics recreationally. Smith said that the environment and company also play a role during psychedelic experiences, stating that having a “reassuring team” around you during such times is “indispensable.”
While many people have shared their experiences with psychedelics, it should be remembered that these substances are potent and could trigger some side effects if improperly used. This could be the reason why entities such as atai Life Sciences N.V. (NASDAQ: ATAI) recommend that psychedelics be used in clinical settings under the supervision of experienced professionals.
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 844-397-5787 (U.S. Mobile Phones Only)
For more information please visit https://www.psychedelicnewswire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.
by Grow Up Conference | Jul 5, 2023 | Garden Culture Magazine, Media Partners
At first glance, my tiny urban townhouse appeared void of viable garden space. Outside the front door, butting up against the concrete wall of the adjacent building, were two 1.5-meter-wide gravel-tiered eyesores. They were eight metres long and full of ferns, cotoneaster, and weeds. It seemed hopeless, but after much trial and error, the space now boasts a small, lush urban garden. You can also transform your space by following my tips for creating a garden in tight spaces.
Observe
As tempting as it was, I didn’t immediately start pulling out the existing foliage; I let the space percolate. I watched the sun’s position and what areas were shadier than others.
I gauged the temperature during hot summer days. Did the large concrete wall cool the garden or, in summer, hold the heat and fry plants? I also took the time to draw how I envisioned the space in each season.
Coherency
Coherency and balance are essential in design. A jumble of colored pots and mismatched furniture can give the eye the illusion of clutter and closed-in space. If there’s a defined theme, the area can appear larger.
I chose a cottage garden theme highlighted by black wrought iron. Trellis, fences and other non-organic additions didn’t have to be identical as long as they maintained a wrought-iron look. It also meant sticking to containers that were either black, grey, or brown and blended with the theme.
Layering
Someone once told me design is like a lasagna; start with the basics and layer. I added structure, like a trellis, small fences, and tall hanging basket hooks.
This step was followed by adding evergreens. The consistent stalwarts of the garden add winter interest and give focal points throughout the year.
Then came deciduous shrubs like hydrangeas. The spaces between were designated for perennials and annuals.
Think To Scale
Every plant in a small space garden uses up real estate. A buddleia, for example, will take up more room than a row of sunflowers or echinacea. Luckily, there are many dwarf varieties of garden favorites available. A Korean dwarf lilac may have smaller flowers but will maintain its height and width at 4-5 metres compared to its taller 10-metre-high cousin.
If the furniture in a small space garden is too large, it can make it seem smaller. Small bistro patio tables are great, as are small two-seat benches tucked into a corner.
Think Vertically
One of the tricks of small-space gardening is to fool the eye into thinking there’s more room than there is. The two tiers of my garden have ledges between them, and I make good use of them and the back wall, which features a line of trellis and intertwining clematis.
The narrow tiers appear much wider than they truly are. If you don’t have ledges, stacking outdoor tables to hold pots or an old bench that gives you more room to add another layer of plants can create the same illusion.
Colors
In a small garden, even if it’s just a patio or apartment balcony, keeping plants in different colors also creates an illusion of space. In the summer, my garden is full of red beebalm, yellow sunflowers, red daylilies, echinacea, pots of crimson geraniums, and New Guinea impatiens.
In the spring, mauve trailing bell flowers, white snowdrift, and the pale purple of the lilac create a softer palette that draws the eye to look beyond to the next part of the garden; it seems to go on forever!
I made many mistakes, but the most important thing I’ve learned is to create a garden reflective of your personality and how you feel when you’re in it. No matter how small – any space can become a place to grow and be part of nature.
by Grow Up Conference | Jul 5, 2023 | Extraction Magazine, Media Partners
Australia made history on July 1 as it became one of the pioneering nations to permit the use of MDMA (ecstasy) and magic mushrooms (psilocybin) for medical treatments, marking a radical shift in addressing certain mental health conditions.
.medrectangle-3-multi-320{border:none !important;display:block !important;float:none !important;line-height:0px;margin-bottom:15px !important;margin-left:auto !important;margin-right:auto !important;margin-top:15px !important;max-width:100% !important;min-height:250px;min-width:250px;padding:0;text-align:center !important;width:100%;}
In an effort to combat post-traumatic stress disorder (PTSD) and some forms of depression, authorized psychiatrists in the country can now prescribe a wider range of substances.
Australia took a significant step forward by reclassifying these drugs entirely following positive results from trials, leading the Therapeutic Goods Administration to deem them “relatively safe” when used in a controlled medical environment back in February’s press-release.
Advocates of this groundbreaking decision are optimistic that MDMA and psilocybin can provide much-needed breakthroughs for individuals battling mental health issues when traditional treatments have proven ineffective. However, authorities in the field claim that it’s not that simple.
Dr. Mike Musker, a mental health researcher at the University of South Australia, emphasized the meticulous monitoring of psychedelic substance use, stating that it would not be a mere “take and go” scenario:
“I have read about stories where people have had what you call bad trips, or actually they’ve re-experienced their trauma, and so we’ve got to take great caution”.
— Mike Musker, University of South Australia, source: AFP News Agency
USA Next?
The recent approval of psychedelic drugs in Australia may have a positive impact on the regulatory processes in the United States.
Canada and the United States have previously authorized the medical use of either MDMA or psilocybin, albeit exclusively within clinical trials or with special permits.
At this point, without any official comments from the FDA, we can say that the result will be largely dependent on the upcoming and previously released trials, involving psychoactive substances.
As one of the milestones for the MDMA part, the U.S. nonprofit Multidisciplinary Association for Psychedelic Studies has recently completed a second phase-three trial on ecastasy as a treatment for PTSD.
The findings of the trial, although yet to be published in a peer-reviewed journal, are expected to reinforce the positive outcomes observed in the initial study, which was published in Nature Medicine in 2021. The results were positive:
“MDMA-assisted therapy is highly efficacious in individuals with severe PTSD, and treatment is safe and well-tolerated, even in those with comorbidities.”
— MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study, 1025–1033 (2021)
Rick Doblin, the founder and executive director of MAPS, expressed confidence in the forthcoming FDA approval process based on their accumulated data:
“It’s going to help regulators in the U.S. and elsewhere feel more comfortable. Regulators don’t like to be the first or the only ones.”
— Rick Doblin, the founder of Multidisciplinary Association for Psychedelic Studies, source: TIME Magazine
As for psilocybin, the process is largely the same: studies first, and when all the paperwork is done, opens the small window for possibilities.
One of the most important pieces of evidence to back psilocybin’s presumed efficiency in clinical setting as a beneficial mental health treatment tool, was published in November, 2022.
The study, “Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression” ended with an overall positive conclusion: “psilocybin at a single dose of 25 mg, but not 10 mg, reduced depression scores significantly more than a 1-mg dose over a period of 3 weeks”.
However, the researchers also mention that a significant part of participants were subject to side effects.
In the middle of 2023, much-needed “larger and longer trials, including comparison with existing treatments”, are yet to be published.
Anything But Cheap
One practical aspect of the decision the experts are confident about is that the official therapy involving psychedelic substances in Australia is going to be costly for the majority of patients.
The major problem with the price of the therapy is the need to factor in multiple normative expenses that were never quite affordable:
- Interdisciplinary team of medical professionals;
- The session itself;
- Hiring a private clinic;
- The need to obtain psychoactive substances themselves from an approved source.
The cost of drugs alone is, according to The Sydney Morning Herald, may be over $1,000 per the amount necessary for a session. All of the aspects combined may spiral the final price tag for the patient up to 30,000 AUD (roughly $20,000), according to BBC source’s calculations.
The precise number is hard to predict before the therapy sessions become widely available. However, according to a philanthropist Peter Hunt of Mind Medicine Australia, the realistic price is about 10,000 AUD. The expert told BBC that they “costed the treatments with a mental health clinic”.
It’s unclear whether there will be any government subsidies or any other forms of financial support to move the new way of treatment forward at a faster pace. According to the industry experts, we can expect things to unravel rather slowly:
“I honestly don’t think, for the next 12 to 18 months post July 1, that these treatments will be very widely available at all. The tight controls of therapy mean there are very few psychologists who put their hand up. There will be a few clinics that open up, but I don’t think we’re going to see the floodgates open.”
— Dr Stephen Bright, director of Psychedelic Research In Science & Medicine, source: Sydney Morning Herald
The final word when it comes to availability will be on the practical benefits for the clinics and patients. According to a Cambridge study on psilocybin-assisted depression treatment cost-effectiveness, published recently, “psilocybin has the potential to be a cost-effective therapy for severe depression.”
by Grow Up Conference | Jul 5, 2023 | Grow Opportunity, Media Partners
(CNW) London — Curaleaf International, part of Curaleaf Holdings and Europe’s largest vertically integrated cannabis company, announced its wholly owned subsidiary, Terra Verde LDA, will acquire the assets of Clever Leaves’ EU-GMP certified cannabis processing facility in Setubal, Portugal.
The acquisition will allow Curaleaf International to streamline its operations and accelerate the seed-to-sale process of its EU-GMP flower products to better serve the rapidly growing European market.
The state-of-the-art facility, which measures over 900 square meters of GMP factory space and 750 square meters of warehousing, will process flower grown at Terra Verde, Curaleaf’s Cultivation facility located in Alcochete, Portugal. These changes will allow Curaleaf to strategically expand its cultivation capacity at Terra Verde to meet the expected growth across Europe, especially within the core markets of the UK and Germany.
“By streamlining our production processes and expanding our cultivation capabilities, Curaleaf International is setting the stage for responsible, robust growth over the next few years as cannabis adoption accelerates across Europe. Curaleaf is the leading producer of consistent, high-grade product throughout the European market, and we will continue to work towards ensuring quality cannabis is available to patients and consumers in the EU and beyond.” — Matt Darin, CEO, Curaleaf
by Grow Up Conference | Jul 5, 2023 | Grow Opportunity, Media Partners
(CNW) Calgary — Acting as exclusive financial advisor to TerrAscend Corp., ATB Capital Markets Inc. is pleased to congratulate TerrAscend on becoming the first cannabis company to list on the Toronto Stock Exchange (TSX) with consolidated financial statements that include revenues from multi-state operations across the United States.
This follows TerrAscend’s three recent closings of its highly successful concurrent private placements for the total aggregate proceeds of approximately US$21 million.
TerrAscend is a leading TSX-listed cannabis company with interests across the North American cannabis sector, including vertically-integrated operations in Pennsylvania, New Jersey, Maryland, Michigan and California through TerrAscend Growth Corp. and retail operations in Canada. TerrAscend Growth’s cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use markets.
“ATB Capital Markets is honoured to act as the trusted partner for our long-standing client, TerrAscend. This landmark moment for TerrAscend to list on the TSX is pivotal to the growth trajectory of TerrAscend and speaks to the continuous evolution of the cannabis industry. Our highly experienced team takes pride in providing specialised advice and access to capital to support the success of our business clients.” — Darren Eurich, CEO, ATB Capital Markets Inc.
by Grow Up Conference | Jul 5, 2023 | Cannabis Prospect Magazine, Media Partners
by Grow Up Conference | Jul 5, 2023 | Cannabis Prospect Magazine, Media Partners
by Grow Up Conference | Jul 5, 2023 | Cannabis Prospect Magazine, Media Partners
by Grow Up Conference | Jul 5, 2023 | Cannabis News Wire, Media Partners
ZJ Events is proud to announce the third leg of its four-part Alternative Products Expo – the Dallas Chapter – that will be held at the Kay Bailey Hutchison Convention Center Dallas. The expo, which promises to be the ultimate event for anyone in the counterculture industry, will serve as a melting pot for everything counterculture, with featured products including CBD, mushrooms, nicotine replacement, dietary supplements, and nootropics, among others.
The event will be held from July 13-15, bringing together hundreds of leading brands such as 3Chi, Mellow Fellow, and Cali Kulture. The event will also offer a platform where attendees can connect with top manufacturers, explore the latest trends and innovations, and even take advantage of exclusive show discounts in a fun and exciting atmosphere.
The Dallas Alternative Products expo will allow business owners to stock their businesses with consumer must-haves. Show-exclusive pricing will make this possible, extending to individual consumers or attendees. The event will also be an excellent avenue for getting updated on trends, new products, and hot sellers in the market while also serving as a one-stop shop for counterculture retail professionals.
The Dallas leg of the 2023 Alternative Products Expo stays true to ZJ Events’ mission to facilitate B2B and B2C networking by vertically incorporating the event’s target industry and its complementary services into an unrivaled trade show experience. By gathering the industry’s best under the same roof while providing attendees with a fun, thrilling experience that promotes business networking, the company is promoting counterculture industry expansion while helping to define a budding sector with incredible potential for growth.
To learn more, please visit https://cnw.fm/M9XqB.
For ticketing info, please visit https://cnw.fm/iecII.
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cannabisnewswire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW? Ask our Editor
CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is part of the InvestorBrandNetwork.
Recent Comments